Xalud Therapeutics, Inc

Open
Website
2120 University Ave Ste 532
Berkeley, CA 94704

Xalud Therapeutics, Inc., based in Berkeley, CA, is a clinical-stage biotechnology company pioneering a non-viral plasmid DNA (pDNA) gene therapy platform aimed at addressing chronic inflammation by restoring immune system balance. Their lead candidate, XT-150, leverages a proprietary version of interleukin-10 (IL-10v) to target various conditions, including musculoskeletal and neurodegenerative diseases, with a focus on treating the root causes of inflammation rather than merely alleviating symptoms.

The company's innovative approach promises adaptability and safety in delivering transgenes for a range of chronic inflammatory, neurological, and autoimmune disorders. Xalud is currently conducting clinical trials for XT-150, including a completed Phase 2b trial for osteoarthritis of the knee, while exploring diverse therapeutic applications through preclinical studies.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesCaliforniaBerkeleyXalud Therapeutics, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.